TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 12, 1974
TCL Archive In Brief: President OK’s Mammography Standard Publication, CDC State Grants Increase January 7, 1994
TCL Archive Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older June 25, 2010
